サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1417204

脳卒中管理市場レポート：2030年までの動向、予測、競合分析

Stroke Management Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

脳卒中管理市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

脳卒中管理の動向と予測

世界の脳卒中管理市場は、2024年から2030年までのCAGRが8.5%で、2030年までに推定651億4,000万米ドルに達すると予想されています。この市場の主な促進要因は、高齢化の進行、冠状動脈性心疾患と高血圧に苦しむ人の数の増加、および脳卒中診断方法の技術の進歩です。世界の脳卒中管理市場の将来は、虚血性脳卒中および出血性脳卒中市場での機会により有望に見えます。

脳卒中管理市場に関する洞察

Lucintelは、脳卒中疾患の早期診断に関する一般の知識の増加による脳卒中診断の増加により、診断が予測期間中に最高の成長を遂げると予想しています。

アジア太平洋地域は、ヘルスケア費の増加と可処分所得の増加により、予測期間中に最高の成長が見込まれると予想されます。

よくある質問

Q.1脳卒中管理の市場規模はどれくらいですか：

A1.世界の脳卒中管理市場は、2030年までに推定651億4,000万米ドルに達すると予想されています。

Q.2脳卒中管理市場の成長予測は何ですか：

A2.世界の脳卒中管理市場は、2024年から2030年にかけて8.5%のCAGRで成長すると予想されています。

Q.3脳卒中管理市場の成長に影響を与える主な要因は何ですか：

A3.この市場の主な促進要因は、高齢化の進行、冠状動脈性心疾患や高血圧に苦しむ人の数の増加、脳卒中診断方法の技術の進歩です。

Q4.市場の主要セグメントは：

A4.脳卒中管理市場の将来は、虚血性脳卒中および出血性脳卒中市場での機会により有望に見えます。

Q5.市場の主要企業は：

A5.主な脳卒中管理会社としては以下のような会社があります。

  • B Braun Melsungen
  • Cardinal Health
  • Medtronic
  • Bristol Myers Squibb
  • Boston Scientific Corporation
  • Abbott Laboratories
  • General Electric Company
  • Merck
  • Siemens
  • Glaxosmithkline

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、脳卒中疾患の早期診断に関する一般の知識の増加による脳卒中診断の増加により、診断が予測期間中に最高の成長を遂げると予想しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.アジア太平洋地域は、ヘルスケア費の増加と可処分所得の増加により、予測期間中に最高の成長が見込まれると予想されます。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の脳卒中管理市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の脳卒中管理市場の動向（2018～2023年）と予測（2024～2030年）
  • タイプ別の世界の脳卒中管理市場
    • 診断
    • 治療学
    • ソフトウェア
  • アプリケーション別の世界の脳卒中管理市場
    • 虚血性脳卒中
    • 出血性脳卒中

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の脳卒中管理市場
  • 北米の脳卒中管理市場
  • 欧州の脳卒中管理市場
  • アジア太平洋地域の脳卒中管理市場
  • その他地域の脳卒中管理市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界の脳卒中管理市場の成長機会
    • アプリケーション別の世界の脳卒中管理市場の成長機会
    • 地域別の世界の脳卒中管理市場の成長機会
  • 世界の脳卒中管理市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の脳卒中管理市場の能力拡大
    • 世界の脳卒中管理市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • B Braun
  • Cardinal Health
  • Medtronic
  • Bristol Myers Squibb
  • Boston Scientific Corporation
  • Abbott Laboratories
  • General Electric Company
  • Merck
  • Siemens
  • NeuraSignal
目次

Stroke Management Trends and Forecast

The future of the global stroke management market looks promising with opportunities in the ischemic stroke and hemorrhagic stroke markets. The global stroke management market is expected to reach an estimated $65.14 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are rise in the population's aging, growing number of individuals suffering from coronary heart disease and hypertension, and advancements in technology for stroke diagnosis methods.

A more than 150-page report is developed to help in your business decisions.

Stroke Management by Segment

The study includes a forecast for the global stroke management by type, application, and region.

Stroke Management Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostics
  • Therapeutics
  • Software

Stroke Management Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Ischemic Stroke
  • Hemorrhagic Stroke

Stroke Management Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Stroke Management Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stroke management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stroke management companies profiled in this report include-

  • B Braun
  • Cardinal Health
  • Medtronic
  • Bristol Myers Squibb
  • Boston Scientific Corporation
  • Abbott Laboratories
  • General Electric Company
  • Merck
  • Siemens
  • Neurasignal

Stroke Management Market Insights

Lucintel forecasts that diagnostics is expected to witness highest growth over the forecast period due to rise in stroke diagnoses as a result of increased public knowledge of early stroke illness diagnosis.

APAC is expected to witness highest growth over the forecast period due to growth in healthcare costs combined with an increase in disposable income.

Features of the Global Stroke Management Market

Market Size Estimates: Stroke management market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Stroke management market size by type, application, and region in terms of value ($B).

Regional Analysis: Stroke management market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the stroke management market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the stroke management market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the stroke management market size?

Answer: The global stroke management market is expected to reach an estimated $65.14 billion by 2030.

Q.2 What is the growth forecast for stroke management market?

Answer: The global stroke management market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the stroke management market?

Answer: The major drivers for this market are rise in the population's aging, growing number of individuals suffering from coronary heart disease and hypertension, and advancements in technology for stroke diagnosis methods.

Q4. What are the major segments for stroke management market?

Answer: The future of the stroke management market looks promising with opportunities in the ischemic stroke and hemorrhagic stroke markets.

Q5. Who are the key stroke management market companies?

Answer: Some of the key stroke management companies are as follows.

  • B Braun Melsungen
  • Cardinal Health
  • Medtronic
  • Bristol Myers Squibb
  • Boston Scientific Corporation
  • Abbott Laboratories
  • General Electric Company
  • Merck
  • Siemens
  • Glaxosmithkline

Q6. Which stroke management market segment will be the largest in future?

Answer: Lucintel forecasts that diagnostics is expected to witness highest growth over the forecast period due to rise in stroke diagnoses as a result of increased public knowledge of early stroke illness diagnosis.

Q7. In stroke management market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growth in healthcare costs combined with an increase in disposable income.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the stroke management market by type (diagnostics and therapeutics), application (ischemic stroke and hemorrhagic stroke), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Stroke Management Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Stroke Management Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Stroke Management Market by Type
    • 3.3.1: Diagnostics
    • 3.3.2: Therapeutics
    • 3.3.3: Software
  • 3.4: Global Stroke Management Market by Application
    • 3.4.1: Ischemic Stroke
    • 3.4.2: Hemorrhagic Stroke

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Stroke Management Market by Region
  • 4.2: North American Stroke Management Market
    • 4.2.2: North American Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke
  • 4.3: European Stroke Management Market
    • 4.3.1: European Stroke Management Market by Type: Diagnostics, Therapeutics, and Software
    • 4.3.2: European Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke
  • 4.4: APAC Stroke Management Market
    • 4.4.1: APAC Stroke Management Market by Type: Diagnostics, Therapeutics, and Software
    • 4.4.2: APAC Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke
  • 4.5: ROW Stroke Management Market
    • 4.5.1: ROW Stroke Management Market by Type: Diagnostics, Therapeutics, and Software
    • 4.5.2: ROW Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Stroke Management Market by Type
    • 6.1.2: Growth Opportunities for the Global Stroke Management Market by Application
    • 6.1.3: Growth Opportunities for the Global Stroke Management Market by Region
  • 6.2: Emerging Trends in the Global Stroke Management Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Stroke Management Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stroke Management Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: B Braun
  • 7.2: Cardinal Health
  • 7.3: Medtronic
  • 7.4: Bristol Myers Squibb
  • 7.5: Boston Scientific Corporation
  • 7.6: Abbott Laboratories
  • 7.7: General Electric Company
  • 7.8: Merck
  • 7.9: Siemens
  • 7.10: NeuraSignal